Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2-{[6-({[(2S,3S,4R,5R)-3-{[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxyoxolan-2-yl]methyl}sulfanyl)hexyl]sulfanyl}-N-{2-[2-(6-amino-9H-purin-9-yl)-N-[({2-[N-(carbamoylmethyl)-2-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)acetamido]ethyl}carbamoyl)methyl]acetamido]ethyl}acetamide
ID: ALA434364
PubChem CID: 44417198
Max Phase: Preclinical
Molecular Formula: C53H88N18O19S2
Molecular Weight: 1345.53
Molecule Type: Small molecule
Associated Items: